{"id":225,"date":"2017-03-18T10:46:18","date_gmt":"2017-03-18T10:46:18","guid":{"rendered":"http:\/\/www.novacos-law.com\/en\/?p=225"},"modified":"2017-03-29T18:59:47","modified_gmt":"2017-03-29T17:59:47","slug":"novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal","status":"publish","type":"post","link":"https:\/\/www.novacos-law.com\/en\/2017\/novacos-advised-dr-kade-on-the-acquisition-of-a-product-portfolio-from-hexal\/","title":{"rendered":"NOVACOS advised DR.KADE on the acquisition of a product portfolio from HEXAL"},"content":{"rendered":"<p>The German pharmaceutical company DR.KADE acquired six phyto-pharmaceutical products from Hexal AG, by this move strengthening one of its core competencies, the gynecology sector. Part of of the acquired portfolio are the well-known products Femikliman<sup>\u00ae<\/sup>\u00a0for treatment of menopausal symptoms and Silicur<sup>\u00ae<\/sup>\u00a0for protection of the liver. The business with the acquired phyto-pharmaceutical products shall in the mid-term provide for 10 percent of DR.KADE&#8217;s total revenues in the OTC sector.<\/p>\n<p>NOVACOS advised DR.KADE on the acquisition with the following team:\u00a0Christian H\u00fcbner (Lead, Partner, M&amp;A\/Life Sciences) and Maria Heil (Partner, M&amp;A\/Life Sciences).<\/p>\n<p>This is our press release (in German language):\u00a0<a href=\"http:\/\/www.novacos-law.com\/en\/wp-content\/uploads\/sites\/3\/2017\/03\/pressemitteilung-novacos-16jan2017.pdf\">Pressemitteilung NOVACOS 16Jan2017<\/a>.<\/p>\n<p>The news coverage by Juve is accessible via the following <a href=\"http:\/\/www.juve.de\/nachrichten\/deals\/2017\/01\/pillen-deal-dr-kade-kauft-mit-clifford-spin-off-novacos-bei-hexal-ein\">link<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The German pharmaceutical company DR.KADE acquired six phyto-pharmaceutical products from Hexal AG, by this move strengthening one of its core competencies, the gynecology sector. Part of of the acquired portfolio are the well-known products Femikliman\u00ae\u00a0for treatment of menopausal symptoms and Silicur\u00ae\u00a0for protection of the liver. The business with the acquired phyto-pharmaceutical products shall in the [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-225","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts\/225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/comments?post=225"}],"version-history":[{"count":0,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/posts\/225\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/media?parent=225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/categories?post=225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.novacos-law.com\/en\/wp-json\/wp\/v2\/tags?post=225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}